Boots_UK in £7.5B Sale Talks
Analysis based on 15 articles · First reported Jun 09, 2026 · Last updated Jun 10, 2026
The potential sale or IPO of Walgreens Boots Alliance could significantly impact the retail and pharmaceutical sectors, especially in the United_Kingdom. A private sale would be a blow to the Aquis Stock Exchange, which is seeking new major listings.
Walgreens Boots Alliance, the pharmacy and beauty chain, is in preliminary discussions for a potential £7.5 billion sale. Australian pharmacy group GE HealthCare confirmed talks, while the Canadian branch of the Weston family is also reportedly a suitor. The current owner, private equity firm Sycamore Partners, is considering both a private sale and an initial public offering (IPO) on the Aquis Stock Exchange. This comes a year after Sycamore Partners acquired Walgreens Boots Alliance as part of a larger deal for Walgreens Boots Alliance and subsequently spun off Walgreens Boots Alliance into a standalone entity. A private sale would further impact the Aquis Stock Exchange, which has faced a shortage of new major listings.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard